Leonard van den Berg: Influence Statistics

Leonard van den Berg

Leonard van den Berg

UMC Utrecht, Utrecht, The Netherlands | Department of Neurology, University Medical Center Utrecht, Utrecht, Netherlands | Department of Neurology, University Medical Centre ...

Leonard van den Berg: Expert Impact

Concepts for which Leonard van den Berg has direct influence: Amyotrophic lateral sclerosis , Olesoxime patients , Patients olesoxime , Amyotrophic lateral , Common variants , Reference panel , Lateral sclerosis .

Leonard van den Berg: KOL impact

Concepts related to the work of other authors for which for which Leonard van den Berg has influence: Amyotrophic lateral sclerosis , Spinal muscular atrophy , Neurodegenerative diseases , Bipolar disorder , Frontotemporal dementia , Axonal transport , Motor neurons .

KOL Resume for Leonard van den Berg

Year
2022

UMC Utrecht, Utrecht, The Netherlands

2021

Department of Neurology, University Medical Center Utrecht, Utrecht, Netherlands

2020

Department of Neurology, University Medical Center Utrecht, Utrecht, the Netherlands

2017

Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom

2015

Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, Utrecht, the, Netherlands, .

2011

Rudolf Magnus Institute of Neuroscience and Department of Neurology, University Medical Centre, 3584 CX Utrecht, the Netherlands,

Prominent publications by Leonard van den Berg

KOL-Index: 14785 . BACKGROUND: Spinal muscular atrophy (SMA) is a progressive motor neuron disease causing loss of motor function and reduced life expectancy, for which limited treatment is available. We investigated the safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 SMA. METHODS: This randomised, double-blind, placebo-controlled, phase 2 study was done in 22 neuromuscular ...
Known for Olesoxime Patients | Type 2 | Spinal Muscular | 3 Sma
KOL-Index: 7066 . Common sequence variants have recently joined rare structural polymorphisms as genetic factors with strong evidence for association with schizophrenia. Here we extend our previous genome-wide association study and meta-analysis (totalling 7 946 cases and 19 036 controls) by examining an expanded set of variants using an enlarged follow-up sample (up to 10 260 cases and 23 500 controls). In ...
Known for Common Variants | Association Schizophrenia | Genetic Factors | Genome Wide
KOL-Index: 5041 . To identify novel genes associated with ALS, we undertook two lines of investigation. We carried out a genome-wide association study comparing 20,806 ALS cases and 59,804 controls. Independently, we performed a rare variant burden analysis comparing 1,138 index familial ALS cases and 19,494 controls. Through both approaches, we identified kinesin family member 5A (KIF5A) as a novel gene ...
Known for Mutations Kif5a | Function Function Mutation | Genome Wide | 20806 Cases
KOL-Index: 4704 . Amyotrophic lateral sclerosis (ALS) is underpinned by an oligogenic rare variant architecture. Identified genetic variants of ALS include RNA-binding proteins containing prion-like domains (PrLDs). We hypothesized that screening genes encoding additional similar proteins will yield novel genetic causes of ALS. The most common genetic variant of ALS patients is a G4C2-repeat expansion ...
Known for Amyotrophic Lateral Sclerosis | Genetic Variants | Rna Binding | Rare Variant
KOL-Index: 2770 . BACKGROUND: There is an urgent unmet need for new therapies in amyotrophic lateral sclerosis. In a clinical study with healthy volunteers, levosimendan, a calcium sensitiser, was shown to improve neuromechanical efficiency and contractile function of the human diaphragm. We aimed to evaluate the safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis, with a ...
Known for Amyotrophic Lateral | Humans Simendan | Respiratory Failure | Sclerosis Focus
KOL-Index: 2405 . OBJECTIVE: Metals have been suggested as a risk factor for amyotrophic lateral sclerosis (ALS), but only retrospective studies are available to date. We compared metal levels in prospectively collected blood samples from ALS patients and controls, to explore whether metals are associated with ALS mortality. METHODS: A nested ALS case-control study was conducted within the prospective EPIC ...
Known for Amyotrophic Lateral | Blood Metal | Cadmium Lead | Lowest Tertile
KOL-Index: 1266 . Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease. CAV1 and CAV2 organize membrane lipid rafts (MLRs) important for cell signaling and neuronal survival, and overexpression of CAV1 ameliorates ALS phenotypes in vivo. Genome-wide association studies localize a large proportion of ALS risk variants within the non-coding genome, but further characterization has ...
Known for Independent Cohort | Neuronal Survival | Amyotrophic Lateral Sclerosis | Membrane Lipid Rafts
KOL-Index: 1158 . We describe a reference panel of 64,976 human haplotypes at 39,235,157 SNPs constructed using whole genome sequence data from 20 studies of predominantly European ancestry. Using this resource leads to accurate genotype imputation at minor allele frequencies as low as 0.1%, a large increase in the number of SNPs tested in association studies and can help to discover and refine causal loci. ...
Known for Reference Panel | European Ancestry | Allele Frequencies | Tested Association
KOL-Index: 198 . OBJECTIVE: Dual leucine zipper kinase (DLK), which regulates the c-Jun N-terminal kinase pathway involved in axon degeneration and apoptosis following neuronal injury, is a potential therapeutic target in amyotrophic lateral sclerosis (ALS). This first-in-human study investigated safety, tolerability, and pharmacokinetics (PK) of oral GDC-0134, a small-molecule DLK inhibitor. Plasma ...
Known for Amyotrophic Lateral Sclerosis

Key People For Amyotrophic Lateral Sclerosis

Top KOLs in the world
#1
Adriano Chio’
amyotrophic lateral sclerosis frontotemporal dementia motor neuron disease
#2
Peter Nigel Leigh
amyotrophic lateral sclerosis motor neuron disease angular complex
#3
Orla M Hardiman
amyotrophic lateral sclerosis polio survivors caregiver burden
#4
Pamela Jean Shaw
amyotrophic lateral sclerosis motor neuron disease spinal cord
#5
Benjamin Rix Brooks
amyotrophic lateral sclerosis spinal cord leukemia virus
#6
AlChalabi Al‐Chalabi
amyotrophic lateral sclerosis frontotemporal dementia repeat expansion

UMC Utrecht, Utrecht, The Netherlands | Department of Neurology, University Medical Center Utrecht, Utrecht, Netherlands | Department of Neurology, University Medical Centre Utrecht Brain Centre, Utrecht University, Utrecht, The Netherlands | Departm